К 49 Clinical Pharmacology / M. J. Brown, P. Sharma, F. A. Mir, P. N. Bennett. - 12th ed.International ed., IE. - Edinburg etc. : Elsevier, 2019 (China). - xiv, 706 p. : il. ; 24 cm. - На англ. мові. - Bibliogr. at the end of the chapt. - Index: p. 667-706. - ISBN 978-0-7020-7328-1. - ISBN 9780-7020-7329-8 IE : 1 767.00 грн Переклад назви: Клінічна фармакологія / М. Браун, П. Шарма, Ф. А. Мір, П. Н. Беннетт
Рубрики: ФАРМАКОЛОГІЯ(АНГЛ) Анотація: The twelfth edition of this long-established textbook of clinical pharmacology (first published in 1960) continues its fine tradition of balancing science and practice for improved evidence-based drug therapy and good prescribing in therapeutic settings increasingly complicated by intercurrent disease and polypharmacy. Coverage of all major therapeutic topics by body system. Introductory sections give brief chapter synopses. Case studies where relevant. Covers the needs of the developing world with a focus on practical prescribing and health technology assessment. Definition, tips, brief explanation boxes throughout. Interesting histories, etymologies and provenances of terms throughout. Entertaining footnotes throughout. New to this Edition Fully updated throughout Table of Contents Section 1: General 1 Clinical pharmacology 2 Topics in drug therapy 3 Discovery and development of drugs 4 Evaluation of drugs in humans 5 Health Technology Assessment 6 Regulation of medicines 7 Classification and naming of drugs Section 2: From Pharmacology to Toxicology 8 General pharmacology 9 Unwanted effects and adverse drug reactions 10 Poisoning, overdose, antidotes 11 Drug dependence Section 3: Infection and Inflammation 12 Chemotherapy of infections 13 Antibacterial drugs 14 Chemotherapy of bacterial infections 15 Viral, fungal, protozoal and helminthic infections 16 Drugs for inflammation and joint disease 17 Drugs and the skin Section 4: Nervous System 18 Pain and analgesics 19 Anaesthesia and neuromuscular block 20 Psychotropic drugs 21 Neurological disorders - epilepsy, Parkinson’s disease, and multiple sclerosis Section 5: Cardiorespiratory and Renal Systems 22 Cholinergic and antimuscarinic (anticholinergic) mechanisms and drugs 23 Adrenergic mechanisms and drugs 24 Arterial hypertension, angina pectoris, myocardial infarction and heart failure 25 Cardiac arrhythmia 26 Hyperlipidaemias 27 Kidney and genitourinary tract 28 Respiratory system Section 6: Blood and Neoplastic Disease 29 Drugs and haemostasis 30 Cellular disorders and anaemias 31 Neoplastic disease and immunosuppression Section 7: Gastrointestinal System 32 Oesophagus, stomach and duodenum 33 Intestines 34 Liver, biliary tract, pancreas Section 8: Endocrine System, Metabolic Conditions 35 Adrenal corticosteroids, antagonists, corticotropin 36 Diabetes mellitus, insulin, oral antidiabetes agents, obesity 37 Thyroid hormones, antithyroid drugs 38 Hypothalamic, pituitary and sex hormones 39 Vitamins, calcium, bone Дод.точки доступу: Brown, Morris J. (MA MSc FRCP FAHA FBPharmacolS FMedSci, Professor of Endocrine Hypertension, William Harvey Research Institute of the Barts and the London School of Medicine and Dentistry, London, UK) Sharma, Pankaj (MD PhD FRCP, Professor of Neurology and Director, Institute of Cardiovascular Research, Royal Holloway College, University of London; and Consultant Neurologist, Imperial College Healthcare NHS Trust, London, UK) Mir, Fraz A. (MA, FRCP, Consultant Clinical Pharmacologist, Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK) Bennett, Peter N. (MD FRCP , Formerly Reader in Clinical Pharmacology, University of Bath, and Consultant Physician, Royal United Hospital, Bath, UK) Примірників всього: 30 ЧЗ (1), Наук.Аб. (28), Гурт.4 (1) Вільні: ЧЗ (1), Наук.Аб. (28), Гурт.4 (1) |